Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /bin/ Disallow: /docs/ Disallow: /js/ Disallow: /styles/ Disallow: /weblogs/ Disallow: /subs/ Disallow: /sitemap/ Disallow: /errors/ User-agent: Libwww-perl Disallow: |
Title | NextSource |
Description | Patient Assistance NextSource Pharmaceuticals is an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating Re-Branding and Launching Matured and Orphan |
Keywords | NextSource Pharmaceuticals, Lomustine, Specialty Pharmaceutical, Enhanced medications, Matured Orphan Drugs, Oncology, Metastatic, Tumors, Products, Learn, CCNU |
WebSite | nextsourcepharma.com |
Host IP | 108.178.52.130 |
Location | United States |
Site | Rank |
US$2,341,964
Last updated: 2023-05-19 20:00:44
nextsourcepharma.com has Semrush global rank of 4,519,415. nextsourcepharma.com has an estimated worth of US$ 2,341,964, based on its estimated Ads revenue. nextsourcepharma.com receives approximately 270,227 unique visitors each day. Its web server is located in United States, with IP address 108.178.52.130. According to SiteAdvisor, nextsourcepharma.com is safe to visit. |
Purchase/Sale Value | US$2,341,964 |
Daily Ads Revenue | US$2,162 |
Monthly Ads Revenue | US$64,855 |
Yearly Ads Revenue | US$778,253 |
Daily Unique Visitors | 18,016 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
nextsourcepharma.com. | A | 3600 | IP: 108.178.52.130 |
nextsourcepharma.com. | NS | 3600 | NS Record: ns2.dotster.com. |
nextsourcepharma.com. | NS | 3600 | NS Record: ns1.dotster.com. |
nextsourcepharma.com. | MX | 1800 | MX Record: 0 nextsourcepharma-com.mail.protection.outlook.com. |
nextsourcepharma.com. | TXT | 1800 | TXT Record: MS=ms39762255 |
nextsourcepharma.com. | TXT | 1800 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
Toggle navigation about us Who we Are Our Solution Contact Us Products Partnerships Our Partner Authorized Distributors Patient Resources News & Media At NextSource, our strategy is to identify, consolidate and procure pharmaceutical products in the U.S. market that are consistently facing supply issues due to manufacturing shortages and product discontinuation. NextSource has created a network of partners that assist us in implementing our proprietary product launch strategy that expedites the approval process and enables us to utilize the strengths of our partner network to restore the unmet healthcare market needs. - Robert DiCrisci, Founder, Chairman & CEO mission statement Previous Next A Statement Regarding Media Coverage of Gleostine ® (lomustine) READ MORE Patient Assistance Program understanding america’s drug shortages Our Global Mission CONTACT US TERMS & CONDITIONS PRIVACY POLICY Copyright © NextSource Pharmaceuticals, LLC 2021 All rights reserved. |
HTTP/1.1 301 Moved Permanently Content-Length: 152 Content-Type: text/html; charset=UTF-8 Location: https://nextsourcepharma.com/ Server: Microsoft-IIS/10.0 X-Powered-By: ASP.NET Date: Wed, 16 Nov 2022 08:50:31 GMT HTTP/2 200 cache-control: private content-length: 13351 content-type: text/html; charset=utf-8 server: Microsoft-IIS/10.0 set-cookie: ASP.NET_SessionId=dsm3p2a05wsrayb1cugfuhfo; path=/; HttpOnly; SameSite=Lax x-aspnet-version: 4.0.30319 x-powered-by: ASP.NET date: Wed, 16 Nov 2022 08:50:31 GMT |
Domain Name: NEXTSOURCEPHARMA.COM Registry Domain ID: 1972964250_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.domain.com Registrar URL: http://www.domain.com Updated Date: 2022-10-13T12:14:56Z Creation Date: 2015-10-28T23:09:19Z Registry Expiry Date: 2023-10-28T23:09:19Z Registrar: Domain.com, LLC Registrar IANA ID: 886 Registrar Abuse Contact Email: compliance@domain-inc.net Registrar Abuse Contact Phone: 602-226-2389 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.DOTSTER.COM Name Server: NS2.DOTSTER.COM DNSSEC: unsigned >>> Last update of whois database: 2022-11-16T08:54:59Z <<< |